Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost

Kazuki Matsuura,1 Ryu Uotani,2 Yuki Terasaka1 1Nojima Hospital, Tottori, Japan; 2Tottori University, Tottori, Japan Purpose: We report the successful treatment of a case of cystoid macular edema (CME) associated with topical tafluprost, which was accompanied by serous retinal detachment (SRD). Case:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matsuura K, Uotani R, Terasaka Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/59b1003105fa457786a26fe79cb28f6b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:59b1003105fa457786a26fe79cb28f6b
record_format dspace
spelling oai:doaj.org-article:59b1003105fa457786a26fe79cb28f6b2021-12-02T01:10:18ZSubtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost1177-54671177-5483https://doaj.org/article/59b1003105fa457786a26fe79cb28f6b2013-07-01T00:00:00Zhttp://www.dovepress.com/subtenon-triamcinolone-injection-for-postoperative-cystoid-macular-ede-a13768https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Kazuki Matsuura,1 Ryu Uotani,2 Yuki Terasaka1 1Nojima Hospital, Tottori, Japan; 2Tottori University, Tottori, Japan Purpose: We report the successful treatment of a case of cystoid macular edema (CME) associated with topical tafluprost, which was accompanied by serous retinal detachment (SRD). Case: A 78-year-old woman underwent intraocular lens suture surgery, including anterior vitreous cutting, for crystalline lens dislocation in the right eye. Tafluprost was initiated 12 weeks after surgery. Intraocular pressure (IOP) was controlled at 10–14 mmHg. Visual acuity remained at 20/40–30/40. However, the patient complained of blurred vision (20/200) 9 months after surgery. CME accompanied by SRD was identified by optical coherence tomography (OCT) and treated with subtenon triamcinolone injection. Visual acuity rapidly increased to 20/50, and the volume of SRD decreased in a few days. Discontinuation of tafluprost and initiation of diclofenac eye drops improved visual acuity to 20/40 and resulted in improved OCT findings within a few weeks. Three months after injection, tafluprost was resumed along with diclofenac. No recurrence of CME occurred over the following 3 months, and IOP was controlled at 10–15 mmHg. Conclusion: SRD is considered to be a symptom of treatment-resistant CME, which may lead to poor visual acuity after recovery. In such cases, subtenon triamcinolone injection should be strongly considered at an early stage. Keywords: tafluprost, cystoid macular edema, serous retinal detachment, subtenon triamcinoloneMatsuura KUotani RTerasaka YDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 1525-1528 (2013)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Matsuura K
Uotani R
Terasaka Y
Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
description Kazuki Matsuura,1 Ryu Uotani,2 Yuki Terasaka1 1Nojima Hospital, Tottori, Japan; 2Tottori University, Tottori, Japan Purpose: We report the successful treatment of a case of cystoid macular edema (CME) associated with topical tafluprost, which was accompanied by serous retinal detachment (SRD). Case: A 78-year-old woman underwent intraocular lens suture surgery, including anterior vitreous cutting, for crystalline lens dislocation in the right eye. Tafluprost was initiated 12 weeks after surgery. Intraocular pressure (IOP) was controlled at 10–14 mmHg. Visual acuity remained at 20/40–30/40. However, the patient complained of blurred vision (20/200) 9 months after surgery. CME accompanied by SRD was identified by optical coherence tomography (OCT) and treated with subtenon triamcinolone injection. Visual acuity rapidly increased to 20/50, and the volume of SRD decreased in a few days. Discontinuation of tafluprost and initiation of diclofenac eye drops improved visual acuity to 20/40 and resulted in improved OCT findings within a few weeks. Three months after injection, tafluprost was resumed along with diclofenac. No recurrence of CME occurred over the following 3 months, and IOP was controlled at 10–15 mmHg. Conclusion: SRD is considered to be a symptom of treatment-resistant CME, which may lead to poor visual acuity after recovery. In such cases, subtenon triamcinolone injection should be strongly considered at an early stage. Keywords: tafluprost, cystoid macular edema, serous retinal detachment, subtenon triamcinolone
format article
author Matsuura K
Uotani R
Terasaka Y
author_facet Matsuura K
Uotani R
Terasaka Y
author_sort Matsuura K
title Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
title_short Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
title_full Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
title_fullStr Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
title_full_unstemmed Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
title_sort subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/59b1003105fa457786a26fe79cb28f6b
work_keys_str_mv AT matsuurak subtenontriamcinoloneinjectionforpostoperativecystoidmacularedemaassociatedwithtafluprost
AT uotanir subtenontriamcinoloneinjectionforpostoperativecystoidmacularedemaassociatedwithtafluprost
AT terasakay subtenontriamcinoloneinjectionforpostoperativecystoidmacularedemaassociatedwithtafluprost
_version_ 1718403256126799872